Cervical Cancer: Our Clinical Trials

In addition to providing excellent care for women with cervical cancer, we lead a number of clinical trials to improve on current standards for treatment and enhance survival and quality of life. We lead clinical trials through our research programs as well as through the efforts of the Gynecologic Oncology Group, a multi-institutional clinical research effort supported by the National Cancer Institute.

Clinical trials are research studies that evaluate the safety and effectiveness of new ways to diagnose and treat cervical cancer. These studies can also help doctors compare the effectiveness of prevention strategies or other aspects of your care.

Our clinical research team is highly experienced in selecting women who are mostly likely to benefit from a particular investigational therapy and in guiding patients through the process of enrolling in the most appropriate clinical trial. If you are eligible to participate in a clinical trial, you may have access to new therapies that are not yet widely available.

The following cervical cancer clinical trials at Memorial Sloan Kettering are currently enrolling patients. To learn more about a study, choose from the list below.

Showing 10 trials
Title Investigator
A Phase I Study of Lurbinectedin plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 13-170]
Drilon, Alexander, MD
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 13-198]
Callahan, Margaret, MD, PhD
A Phase III Clinical Trial of Adjuvant Radiation versus Chemoradiation in Patients with Intermediate-Risk, Stage I/IIA Cervical Cancer Treated with Surgery
[Protocol 11-007]
Leitao, Mario, MD
A Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Cancer Following Radical Hysterectomy
[Protocol 10-173]
Leitao, Mario, MD
A Phase III Study Assessing Chemoradiation Alone and with Additional Chemotherapy in Women with Locally Advanced, Inoperable Cervical Cancer: The OUTBACK Trial
[Protocol 12-171]
Leitao, Mario, MD
A Pilot Study of Ribavirin to Treat Recurrent or Metastatic HPV-Related Cancers
[Protocol 14-211]
Fury, Matthew, MD, PhD
A Study Assessing Fluorestradiol PET/CT for Imaging Estrogen Receptor Status
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-071]
Ulaner, Gary, MD, PhD
A Study of an Online Support Group for Women Experiencing Sexual Distress due to a Gynecologic Cancer
[Protocol 14-245]
Carter, Jeanne, PhD
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life
[Protocol 08-155]
Chi, Dennis, MD
Evaluation of Physical Function and Quality of Life Before and After Non-Radical Surgery for Stage I Cervical Cancer
Newly Diagnosed
[Protocol 13-210]
Leitao, Mario, MD